
William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SNH865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until October 8, 2027.
C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca, BeOne Medicines, and Lilly.
Disclosure information is available at the beginning of the video presentation.
Flere episoder fra "PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast"



Gå ikke glip af nogen episoder af “PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast” - abonnér på podcasten med gratisapp GetPodcast.








